WeVote

Bill

Bill

SF 399

A bill for an act relating to the licensure of medical cannabidiol dispensaries.

2025-2026 Regular Session

Iowa SF 399 would establish licensing requirements for medical cannabidiol dispensaries, creating regulatory oversight and legal access pathways for CBD products.

Subcommittee: Webster, Gruenhagen, and Knox.
0
WeVote Research Nonpartisan
Bill Summary · SF 399

Legislative bill overview

SF 399 proposes to establish a licensing framework for medical cannabidiol (CBD) dispensaries in Iowa. The bill would create regulatory standards for businesses seeking to distribute medical CBD products to qualified patients. This represents an expansion of Iowa's existing medical cannabis regulations to specifically accommodate CBD distribution.

Why is this important

Medical CBD has gained traction as a treatment option for conditions like epilepsy, chronic pain, and anxiety, and many patients seek legal access to tested products. Establishing a formal licensing system would provide consumer protections, quality assurance, and tax revenue while clarifying the legal status of CBD dispensaries currently operating in a regulatory gray area. This could also position Iowa competitively among states developing regulated medical CBD markets.

Potential points of contention

  • Federal-state legal tension: CBD remains federally ambiguous despite the 2018 Farm Bill, creating uncertainty about whether state licensure adequately protects businesses and consumers from federal enforcement
  • Scope and potency limits: Disagreement may arise over what CBD concentration levels qualify as "medical" versus recreational, and whether products containing trace THC should be permitted
  • Market competition concerns: Existing medical marijuana licensees may oppose CBD-specific dispensaries as market competition, while CBD advocates may argue separate licensing is unnecessarily restrictive

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.